Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Viritis
Viritis Overview
Viritis is developing a molecular platform for creating specific antiviral treatments against almost all viruses. The first indication is for Influenza virus and other viruses that attacks the respiratory system such as RSV, COVID-19 and others. After successful POC in-vitro testing and patent application in the national stage in US, Europe, India and China, Viritis is looking for partners and investors that will enable it to push forward.